644 related articles for article (PubMed ID: 27565153)
1. Defining optimal tracer activities in pediatric oncologic whole-body
Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
[TBL] [Abstract][Full Text] [Related]
2. Simulation of Tracer Dose Reduction in
Seith F; Schmidt H; Kunz J; Küstner T; Gatidis S; Nikolaou K; la Fougère C; Schwenzer N
J Nucl Med; 2017 Oct; 58(10):1699-1705. PubMed ID: 28360205
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of image metrics for reduced and standard dose pediatric
Zucchetta P; Branchini M; Zorz A; Bodanza V; Cecchin D; Paiusco M; Bui F
Br J Radiol; 2019 Mar; 92(1095):20180438. PubMed ID: 30673306
[TBL] [Abstract][Full Text] [Related]
5. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
Ponisio MR; McConathy J; Laforest R; Khanna G
Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
[TBL] [Abstract][Full Text] [Related]
7. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
Everaert H; Vanhove C; Lahoutte T; Muylle K; Caveliers V; Bossuyt A; Franken PR
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1615-9. PubMed ID: 14504831
[TBL] [Abstract][Full Text] [Related]
8. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
9. [Simultaneous whole-body PET-MRI in pediatric oncology : More than just reducing radiation?].
Gatidis S; Gückel B; la Fougère C; Schmitt J; Schäfer JF
Radiologe; 2016 Jul; 56(7):622-30. PubMed ID: 27306199
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and visual analyses of the effect of activity reduction on image metrics and quality in 18F-FDG PET/MRI in pediatric oncology.
Aydos U; Balcı E; Ateş SG; Akdemir ÜÖ; Karadeniz C; Atay LÖ
Turk J Med Sci; 2023 Feb; 53(1):289-302. PubMed ID: 36945939
[TBL] [Abstract][Full Text] [Related]
11. Towards tracer dose reduction in PET studies: Simulation of dose reduction by retrospective randomized undersampling of list-mode data.
Gatidis S; Würslin C; Seith F; Schäfer JF; la Fougère C; Nikolaou K; Schwenzer NF; Schmidt H
Hell J Nucl Med; 2016; 19(1):15-8. PubMed ID: 26929936
[TBL] [Abstract][Full Text] [Related]
12. Comparison of FDG PET/MRI and FDG PET/CT in Pediatric Oncology in Terms of Anatomic Correlation of FDG-positive Lesions.
Uslu-Beşli L; Atay Kapucu LÖ; Karadeniz C; Akdemir ÜÖ; Pinarli FG; Aydos U; Okur A; Kaya Z; Samanci C; Karabacak NI
J Pediatr Hematol Oncol; 2019 Oct; 41(7):542-550. PubMed ID: 30933019
[TBL] [Abstract][Full Text] [Related]
13. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
[TBL] [Abstract][Full Text] [Related]
14. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of
Sah BR; Ghafoor S; Burger IA; Ter Voert EEGW; Sekine T; Delso G; Huellner M; Dedes KJ; Boss A; Veit-Haibach P
J Nucl Med; 2018 Dec; 59(12):1817-1822. PubMed ID: 29880506
[TBL] [Abstract][Full Text] [Related]
16. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
17. Image quality and lesion detectability in low-dose pediatric
Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
[TBL] [Abstract][Full Text] [Related]
18. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
[No Abstract] [Full Text] [Related]
19. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of PET image reconstruction using a spatial resolution model.
Andersen FL; Klausen TL; Loft A; Beyer T; Holm S
Eur J Radiol; 2013 May; 82(5):862-9. PubMed ID: 23254158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
